ChinHurMD

Esophagus Disease, Gastrointestinal Cancer

Professor of Medicine

Overview of Dr. Hur

Dr. Chin Hur is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 22 years. He specializes in esophagus disease and gastrointestinal cancer.

Office
161 Fort Washington Avenue
New York, NY 10032
Book by Phone+1(813) 756-2132

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Gastroenterology, 1999 - 2002
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
Johns Hopkins University School of MedicineClass of 1995

Certifications & Licensure

NY State Medical License 2018 - 2025
MA State Medical License 1998 - 2019

Clinical Trials

Decision Aid for Gastroesophageal Reflux Disease Management Start of enrollment: 2014 Jan 01
Unknown status
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps Start of enrollment: 2014 Jun 23
Active, not recruiting
Phase 2
Detection of Gastrointestinal Bleeding in Intensive Care Patients Via Biosensor Watch Start of enrollment: 2019 Mar 29
Terminated

Publications & Presentations

PubMed

MODELING EARLY-ONSET CANCER KINETICS TO STUDY CHANGES IN UNDERLYING RISK, DETECTION, AND IMPACT OF POPULATION SCREENING.
Navid Mohammad Mirzaei, Chin Hur, Mary Beth Terry, Piero Dalerba, Wan Yang
Medrxiv. 2024-12-08
Comments on Recently Published Cost-Effectiveness Analyses on Liquid Biopsy for Colorectal Cancer Screening.
Zainab Aziz, Sheila Rustgi, Chin Hur
Gastroenterology. 2024-12-01
A High-Resolution Microendoscope Improves Esophageal Cancer Screening and Surveillance: Implications for Underserved Global Settings Based on an International Randomiz...
Mimi C Tan, Zhengqi Li, Kalpesh K Patel, Fan Zhang, Xinying Yu
Gastroenterology. 2024-10-29

Journal Articles

Survival Disparities by Race and Ethnicity in Early Esophageal Cancer
Chin Hur, Ryan Nipp, Digestive Diseases and Sciences

Authored Content

Mo1123 CRYOTHERAPY (TRUFREEZE™) VS. RADIO FREQUENCY ABLATION (BARRX™) FOR THE TREATMENT OF BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND/OR EARLY ADENOCARCINOMA: AD INTERIM RESULTS OF A NON-INFERIORITY RANDOMIZED CLINICAL TRIALMay 2018
Mo1123 CRYOTHERAPY (TRUFREEZE™) VS. RADIO FREQUENCY ABLATION (BARRX™) FOR THE TREATMENT OF BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND/OR EARLY ADENOCARCINOMA: AD INTERIM RESULTS OF A NON-INFERIORITY RANDOMIZED CLINICAL TRIALMay 2018

Press Mentions

Velocity Raises More Than $1.1 Million to End CancerNovember 28th, 2022
Gastric Bypass Better for Type 2 DiabeticsFebruary 16th, 2022
Gastric Bypass Most Cost-Effective for Severe Obesity, T2D?February 14th, 2022
Join now to see all

Professional Memberships

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Massachusetts Blue Care Elect PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPO
Harvard Pilgrim HMO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Tufts Health Plan PPO
UniCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment